Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Paricalcitol
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Paricalcitol 1microgram capsules
0906040P0AAACAC
|
Paricalcitol | Paricalcitol | Nutrition and Blood | 50 |
|
Paricalcitol 2microgram capsules
0906040P0AAADAD
|
Paricalcitol | Paricalcitol | Nutrition and Blood | 28 |
|
Zemplar 1microgram capsules
0906040P0BBACAC
|
Zemplar | Paricalcitol | Nutrition and Blood | 19 |
|
Paricalcitol 10micrograms/2ml inj ampoules
0906040P0AAABAB
|
Paricalcitol | Paricalcitol | Nutrition and Blood | No data available |
|
Paricalcitol 4microgram capsules
0906040P0AAAEAE
|
Paricalcitol | Paricalcitol | Nutrition and Blood | No data available |
|
Paricalcitol 5micrograms/1ml solution for injection ampoules
0906040P0AAAAAA
|
Paricalcitol | Paricalcitol | Nutrition and Blood | No data available |
|
Paricalcitol 5micrograms/1ml solution for injection vials
0906040P0AAAFAF
|
Paricalcitol | Paricalcitol | Nutrition and Blood | No data available |
|
Zemplar 10micrograms/2ml solution for injection ampoules
0906040P0BBABAB
|
Zemplar | Paricalcitol | Nutrition and Blood | No data available |
|
Zemplar 2microgram capsules
0906040P0BBADAD
|
Zemplar | Paricalcitol | Nutrition and Blood | No data available |
|
Zemplar 4microgram capsules
0906040P0BBAEAE
|
Zemplar | Paricalcitol | Nutrition and Blood | No data available |
|
Zemplar 5micrograms/1ml solution for injection ampoules
0906040P0BBAAAA
|
Zemplar | Paricalcitol | Nutrition and Blood | No data available |
|
Zemplar 5micrograms/1ml solution for injection vials
0906040P0BBAFAF
|
Zemplar | Paricalcitol | Nutrition and Blood | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.